Back to Search
KAREN TEDESCO, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1083601124IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
231176(NY)
Education
STATE UNIVERSITY OF NY UPSTATE MEDICAL UNIVERSITY
Class of 1998
Research & Publications (8)
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.
PMID 19459042·Breast Cancer Res Treat·2009
3-trial
Increased cochlear fluid-attenuated inversion recovery signal in patients with vestibular schwannoma.
PMID 18238842·AJNR Am J Neuroradiol·2008
8-other
A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas.
PMID 15921772·Radiother Oncol·2005
3-trial
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
PMID 15817338·Int J Radiat Oncol Biol Phys·2005
3-trial
The epidermal growth factor receptor as a target for gastrointestinal cancer therapy.
PMID 15341677·Curr Treat Options Oncol·2004
6-review
Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial.
PMID 15020608·J Clin Oncol·2004
3-trial
Prostate cancer early detection practices among men with a family history of disease.
PMID 12946749·Urology·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1700 RIVERFRONT CTR
AMSTERDAM, NY 12010 - Phone
- (518) 843-0020
Quick Facts
- NPI
- 1083601124
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 8
Are you this provider?
Claim Your Profile